Drug Shortage Report for INNOHEP
Report ID | 88440 |
Drug Identification Number | 02358174 |
Brand name | INNOHEP |
Common or Proper name | Tinzaparin sodium |
Company Name | LEO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TINZAPARIN SODIUM |
Strength(s) | 20000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 10 x 0.7mL syringe |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-07-04 |
Actual start date | 2019-07-04 |
Estimated end date | |
Actual end date | 2019-10-24 |
Shortage status | Resolved |
Updated date | 2019-10-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3389 STEELES AVENUE EAST, SUITE 110 TORONTO, ONTARIO CANADA M2H 3S8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-03 | English | Compare |
v2 | 2019-07-03 | French | Compare |
v3 | 2019-07-05 | English | Compare |
v4 | 2019-07-29 | English | Compare |
v5 | 2019-07-29 | French | Compare |
v6 | 2019-10-10 | English | Compare |
v7 | 2019-10-10 | French | Compare |
v8 | 2019-10-24 | English | Compare |
v9 | 2019-10-24 | French | Compare |
Showing 1 to 9 of 9